These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 2611521)

  • 1. Behavioural indices of the interaction of clozapine with D1 and D2 dopamine receptors.
    Murray AM; Waddington JL
    Br J Pharmacol; 1989 Dec; 98 Suppl():814P. PubMed ID: 2611521
    [No Abstract]   [Full Text] [Related]  

  • 2. Clozapine: neuroendocrine studies of an atypical neuroleptic.
    Meltzer HY; Nash JF; Koenig JI; Gudelsky GA
    Clin Neuropharmacol; 1986; 9 Suppl 4():316-8. PubMed ID: 2882843
    [No Abstract]   [Full Text] [Related]  

  • 3. Behavioral and biochemical correlates after haloperidol and clozapine long-term treatment.
    Racagni G; Bruno F; Bugatti A; Parenti M; Apud JA; Santini V; Carenzi A; Groppetti A; Cattabeni F
    Adv Biochem Psychopharmacol; 1980; 24():45-51. PubMed ID: 7405672
    [No Abstract]   [Full Text] [Related]  

  • 4. Loxapine and clozapine decrease serotonin (S2) but do not elevate dopamine (D2) receptor numbers in the rat brain.
    Lee T; Tang SW
    Psychiatry Res; 1984 Aug; 12(4):277-85. PubMed ID: 6239298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
    Hess EJ; Albers LJ; Le H; Creese I
    J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology of fluperlapine compared with clozapine.
    Eichenberger E
    Arzneimittelforschung; 1984; 34(1A):110-3. PubMed ID: 6145425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurobehavioral evidence for mesolimbic specificity of action by clozapine: studies using electrical intracranial self-stimulation.
    Gardner EL; Seeger TF
    Biol Psychiatry; 1983 Dec; 18(12):1357-62. PubMed ID: 6661466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of clozapine and other dibenzo-epines on central dopaminergic and cholinergic systems. Structure-activity relationships.
    Bürki HR; Sayers AC; Ruch W; Asper H
    Arzneimittelforschung; 1977; 27(8):1561-5. PubMed ID: 20900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of clozapine on the behavioral and electrographic indices of the arrest function of the caudate nucleus in cats].
    Arushanian EB; Tolpyshev BA
    Biull Eksp Biol Med; 1978 May; 85(5):541-4. PubMed ID: 566138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential sensitivity to amphetamine following long-term treatment with clozapine or haloperidol.
    Rebec GV; Peirson EE; McPherson FA; Brugge K
    Psychopharmacology (Berl); 1982; 77(4):360-6. PubMed ID: 6813898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute treatment with clozapine blocks D1 dopamine receptor binding in discrete brain areas of the male rat.
    Fuxe K; von Euler G; Agnati LF; Saller CF; Salama A; Goldstein M
    Neurosci Lett; 1989 Nov; 106(1-2):169-74. PubMed ID: 2531306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cloxazepine: neuropharmacological studies].
    Stefanova D
    Eksp Med Morfol; 1981; 20(4):208-13. PubMed ID: 7327147
    [No Abstract]   [Full Text] [Related]  

  • 13. Behavioral, anti-dopaminergic, and prohypnotic effects of neuroleptics during and after prolonged treatment.
    Biazzi A; Fregnan GB
    Adv Biochem Psychopharmacol; 1980; 24():351-7. PubMed ID: 6105785
    [No Abstract]   [Full Text] [Related]  

  • 14. Clozapine and haloperidol in the amygdaloid complex: differential effects on dopamine transmission with long-term treatment.
    Anderson GD; Rebec GV
    Biol Psychiatry; 1988 Mar; 23(5):497-506. PubMed ID: 2830920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striatal dopamine receptors in rats displaying long-term behavioural sensitization to morphine.
    Nestby P; Schotte A; Janssen PF; Tjon GH; Vanderschuren LJ; De Vries TJ; Mulder AH; Leysen JE; Schoffelmeer AN
    Synapse; 1997 Nov; 27(3):262-5. PubMed ID: 9329160
    [No Abstract]   [Full Text] [Related]  

  • 16. Dopamine receptor pharmacology.
    Seeman P; Van Tol HH
    Curr Opin Neurol Neurosurg; 1993 Aug; 6(4):602-8. PubMed ID: 8104554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of the behavioral effects of the selective dopamine D2 agonist (+)-4-propyl-9-hydroxynaphthoxazine by dopamine antagonists in monkeys.
    Rosenzweig-Lipson S; Bergman J
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1039-46. PubMed ID: 8099614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of haloperidol and low dose clozapine on the acetylcholine turnover rate in rat forebrain structures.
    Bluth R; Langnickel R
    Biomed Biochim Acta; 1985; 44(10):1531-9. PubMed ID: 4084256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological profile of AD-5423, a novel antipsychotic with both potent dopamine-D2 and serotonin-S2 antagonist properties.
    Oka M; Noda Y; Ochi Y; Furukawa K; Une T; Kurumiya S; Hino K; Karasawa T
    J Pharmacol Exp Ther; 1993 Jan; 264(1):158-65. PubMed ID: 8093723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dibenzazecine compounds with a novel dopamine/5HT2A receptor profile and 3D-QSAR analysis.
    Hamacher A; Weigt M; Wiese M; Hoefgen B; Lehmann J; Kassack MU
    BMC Pharmacol; 2006 Sep; 6():11. PubMed ID: 16978403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.